Search Results
debutylbupivacaine 50 mg | Purity Not Available
TargetMol

Debutylbupivacaine is the intermediate of ropivacaine hydrochloride and bupivacaine.
More Information Supplier Pagedebutylbupivacaine 25 mg | Purity Not Available
TargetMol

Debutylbupivacaine is the intermediate of ropivacaine hydrochloride and bupivacaine.
More Information Supplier Pagedebutylbupivacaine 100 mg | Purity Not Available
TargetMol

Debutylbupivacaine is the intermediate of ropivacaine hydrochloride and bupivacaine.
More Information Supplier PageAzasetron hydrochloride 10 mg | 99.85%
TargetMol

Azasetron Hydrochloride is a 5-HT3 receptor antagonist which is used as an anti-emetic.
More Information Supplier PageAzasetron hydrochloride 25 mg | 99.85%
TargetMol

Azasetron Hydrochloride is a 5-HT3 receptor antagonist which is used as an anti-emetic.
More Information Supplier PageMitiglinide calcium hydrate 100 mg | Purity Not Available
TargetMol

Mitiglinide calcium hydrate (S-21403 calcium hydrate) is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda.
More Information Supplier PageDarifenacin hydrobromide 100 mg | 99.71%
TargetMol

Darifenacin hydrobromide (UK-88525) is a selective muscarinic receptor antagonist used to treat urinary incontinence and overactive bladder syndrome.
More Information Supplier PageDrospirenone 100 mg | 99.85%
TargetMol

Drospirenone is a synthetic spironolactone analogue and progestin with progestational and anti-mineralocorticoid activity.
More Information Supplier PageDrospirenone 25 mg | 99.85%
TargetMol

Drospirenone is a synthetic spironolactone analogue and progestin with progestational and anti-mineralocorticoid activity.
More Information Supplier Page